Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Barbara J. Kuter, Gary S. Marshall, Jaime Fergie, Elvira Schmidt & Manjiri Pawaskar. (2024) Prevention of measles, mumps and rubella: 40 years of global experience with M-M-RII. Human Vaccines & Immunotherapeutics 17:12, pages 5372-5383.
Read now
Read now
Md Ahsan Habib, Michael Povey, Giacomo Casabona, Tina Singh & Remon Abu-Elyazeed. (2023) Clinical trials show similar safety outcomes including febrile convulsion rates for GSK’s and Merck’s measles-mumps-rubella (MMR) vaccines. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Catherine Huoi, Juan Vargas-Zambrano, Denis Macina & Emmanuel Vidor. (2022) A combined DTaP-IPV vaccine (Tetraxim®/Tetravac®) used as school-entry booster: a review of more than 20 years of clinical and post-marketing experience. Expert Review of Vaccines 21:9, pages 1215-1231.
Read now
Read now
Articles from other publishers (6)
Kimberly N. Garces, Alexandra N. Cocores, Peter J. Goadsby & Teshamae S. Monteith. (2022) Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting. Current Pain and Headache Reports 26:12, pages 895-918.
Crossref
Crossref
Elisabeth Krow-Lucal, Mona Marin, Leah Shepersky, Lynn Bahta, Jamie Loehr & Kathleen Dooling. (2022) Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022. MMWR. Morbidity and Mortality Weekly Report 71:46, pages 1465-1470.
Crossref
Crossref
Yuguo Zhang, Musa Gabere, Mika A. Taylor, Camila C. Simoes, Chelsae Dumbauld, Oumar Barro, Mulu Z. Tesfay, Alicia L. Graham, Khandoker Usran Ferdous, Alena V. Savenka, Jean Christopher Chamcheu, Charity L. Washam, Duah Alkam, Allen Gies, Stephanie D. Byrum, Matteo Conti, Steven R. Post, Thomas Kelly, Mitesh J. Borad, Martin J. Cannon, Alexei Basnakian & Bolni M. Nagalo. (2022) Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy. Frontiers in Oncology 12.
Crossref
Crossref
Jorgen Bauwens, Simon de Lusignan, Yonas Ghebremichael Weldesselassie, Julian Sherlock, Nino Künzli & Jan Bonhoeffer. (2022) Safety of routine childhood vaccine coadministration versus separate vaccination. BMJ Global Health 7:9, pages e008215.
Crossref
Crossref
Ousseny Zerbo, Sharareh Modaressi, Kristin Goddard, Edwin Lewis, Bruce Fireman, Matthew F. Daley, Stephanie A. Irving, Lisa A. Jackson, James G. Donahue, Lei Qian, Darios Getahun, Frank DeStefano, Michael M. McNeil & Nicola P. Klein. (2022) Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders. Vaccine 40:18, pages 2568-2573.
Crossref
Crossref
Mawuli Nyaku, Elizabeth Richardson, Federico Martinon-TorresBarbara J. Kuter. (2021) Evaluation of the Safety and Immunogenicity of M-M-RII (Combination Measles-mumps-rubella Vaccine). Pediatric Infectious Disease Journal 40:11, pages 1046-1054.
Crossref
Crossref